mark cuban pharmacy glp 1 Cost Plus Drugs partners with 9amHealth on GLP-1 drugs Penn Medicine joins Mark Cuban's

The Weill Cornell cohort study (255 GLP-1RA subjects, 92% women, mean age 64) found that greater annualized hip bone loss was concentrated in patients without diabetes - exactly the demographic of postmenopausal women using GLP-1s purely for weight management

The national burden of asthma has been estimated at 17.23 million, with an overall prevalence of 2.05%

Patients sometimes think GLP-1 medications are unrelated to surgery because they are just weight loss injections. They are absolutely relevant to anesthesia safety

Company Heat Map Analysis, 2024 8.5

Fehse F, Trautmann M, Holst JJ, Halseth AE, Nanayakkara N, Nielsen LL, Fineman MS, Kim DD, Nauck MA